Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Shareholder vote results
  2. 8-K Event Results of operations
  3. DEF 14A Proxy Proxy Statement
  4. 10-K Report Annual Report
  5. 8-K Event Results of operations
  6. 8-K Event Other events
  7. 8-K Event Other events
  8. 8-K Event Results of operations · Executive or director change
  9. 8-K Event Material agreement · Regulation FD disclosure
  10. 8-K Event Results of operations
  11. 8-K Event Other events
  12. 10-K/A Report 10-K/A
  13. 8-K Event Shareholder vote results
  14. 8-K Event Material agreement · Acquisition or sale completed · Regulation FD disclosure
  15. 8-K Event Results of operations
  16. 8-K Event Material agreement · New debt or obligation
  17. DEF 14A Proxy Proxy Statement
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations · Executive or director change
  20. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure

Page 6 of 7 · 121 filings